相似文献
1
Cefoperazone Induced Gastrointestinal Bleeding.
J Clin Diagn Res. 2016 Aug;10(8):OD10-1. doi: 10.7860/JCDR/2016/19694.8316. Epub 2016 Aug 1.
2
Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.
Drug Saf Case Rep. 2016 Dec;3(1):2. doi: 10.1007/s40800-016-0025-9.
3
Cefoperazone-induced Coagulopathy in Critically Ill Patients Admitted to Intensive Care Unit.
Indian J Crit Care Med. 2023 Mar;27(3):183-189. doi: 10.5005/jp-journals-10071-24417.
4
Fatal Vitamin K-Dependent Coagulopathy Associated with Cefoperazone/Sulbactam: A Case Report.
Drug Saf Case Rep. 2019 Jun 14;6(1):6. doi: 10.1007/s40800-019-0100-0.
5
Hypoprothrombinaemia and bleeding during administration of cefamandole and cefoperazone. Report of three cases.
Ann Clin Res. 1985;17(3):116-9.
6
Cefoperazone induced gastro-intestinal haemorrhage. A case report.
Acta Chir Belg. 2008 Nov-Dec;108(6):777-8. doi: 10.1080/00015458.2008.11680339.
7
Coagulopathy and hemorrhage associated with cefoperazone therapy in a patient with renal failure.
South Med J. 1985 Apr;78(4):488-9. doi: 10.1097/00007611-198504000-00035.
8
Hypoprothrombinemia associated with cefoperazone therapy.
South Med J. 1987 Nov;80(11):1360-2. doi: 10.1097/00007611-198711000-00007.
9
[Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
Arzneimittelforschung. 1989 Sep;39(9):1156-62.
10
Safety of cefotaxime and other new beta-lactam antibiotics.
J Antimicrob Chemother. 1984 Sep;14 Suppl B:331-5. doi: 10.1093/jac/14.suppl_b.331.
引用本文的文献
1
Cefoperazone-Sulbactam-Induced Coagulopathy in Critically Ill Egyptian Patients: Role of Vitamin K Prophylactic Doses.
Hosp Pharm. 2024 Oct;59(5):575-583. doi: 10.1177/00185787241238310. Epub 2024 Mar 13.
2
Severe coagulopathy caused by cefminox sodium in a liver cirrhosis patient: a case report.
Infect Agent Cancer. 2022 Jun 16;17(1):30. doi: 10.1186/s13027-022-00446-y.
3
Fatal Vitamin K-Dependent Coagulopathy Associated with Cefoperazone/Sulbactam: A Case Report.
Drug Saf Case Rep. 2019 Jun 14;6(1):6. doi: 10.1007/s40800-019-0100-0.
4
An overview of cephalosporin antibiotics as emerging contaminants: a serious environmental concern.
3 Biotech. 2019 Jun;9(6):231. doi: 10.1007/s13205-019-1766-9. Epub 2019 May 24.
本文引用的文献
1
Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature.
Drug Saf Case Rep. 2016 Dec;3(1):2. doi: 10.1007/s40800-016-0025-9.
2
Role of prophylactic vitamin K in preventing antibiotic induced hypoprothrombinemia.
Indian J Pediatr. 2015 Apr;82(4):363-7. doi: 10.1007/s12098-014-1584-3. Epub 2014 Oct 10.
3
Cefoperazone induced gastro-intestinal haemorrhage. A case report.
Acta Chir Belg. 2008 Nov-Dec;108(6):777-8. doi: 10.1080/00015458.2008.11680339.
4
Vitamin K deficiency bleeding (VKDB) in early infancy.
Blood Rev. 2009 Mar;23(2):49-59. doi: 10.1016/j.blre.2008.06.001. Epub 2008 Sep 19.
5
Risk of bleeding and hypoprothrombinaemia associated with NMTT side chain antibiotics: using cefoperazone as a test case.
Pharmacoepidemiol Drug Saf. 1999 Mar;8(2):81-94. doi: 10.1002/(SICI)1099-1557(199903/04)8:2<81::AID-PDS411>3.0.CO;2-G.
6
Third-generation cephalosporins.
Med Clin North Am. 1995 Jul;79(4):705-19. doi: 10.1016/s0025-7125(16)30034-7.
7
Hypoprothrombinemia associated with cefoperazone treatment.
Drug Intell Clin Pharm. 1984 Apr;18(4):314-6. doi: 10.1177/106002808401800410.
8
Hypoprothrombinaemia and bleeding during administration of cefamandole and cefoperazone. Report of three cases.
Ann Clin Res. 1985;17(3):116-9.
9
Hypoprothrombinemia associated with cefoperazone therapy.
South Med J. 1987 Nov;80(11):1360-2. doi: 10.1097/00007611-198711000-00007.
10
Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.
J Clin Pharmacol. 1988 Jan;28(1):88-95. doi: 10.1002/j.1552-4604.1988.tb03106.x.
Zotero 插件